Recurrent prostate cancer: Two treatment strategies with uncertain outcomes compared
Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy. Matched analyses estimated 10-year cancer-specific survival at 92% ...









